Tag: Patient

Categories
Health

Marc Lewitinn, Covid Affected person, Dies at 76 After 850 Days on a Ventilator

Marc Lewitinn, Covid Patient, Dies at 76 After 850 Days on a Ventilator

None of them come close to Mr Levitinn’s streak, a combination, doctors say, of his physical and mental strength and the speed with which the medical establishment has developed protocols for long-term care for Covid.

“He had a long and difficult road,” wrote Dr. Abraham Sanders, one of his doctors at Weill Cornell, in an email. “He was a strong man and benefited from sophisticated medical care.”

Murad Albert Lewitinn was born on March 12, 1946 into a Jewish family in Cairo. (As a child, he anglicized his first name to Marco and later dropped the O.) His father, Albert Lewitinn, was a medical technician and his mother, Sarah (Amiga) Lewitinn, was a homemaker. He grew up speaking Arabic and later learned English, French and Spanish.

Egypt had a thriving Jewish community of 75,000, but after the Arab nationalist revolution in 1952 and the Suez Crisis in 1956, which pitted the country against Israel, France and Britain, they faced deteriorating conditions. The government took over the elderly Mr. Lewitinn’s business, and after a brief imprisonment, he and his family were expelled in 1958.

They settled in Baltimore, where Albert Lewitinn was hired by Johns Hopkins University to work on organ transplant technology.

As a young man, Marc lived in New York City and Los Angeles, where he briefly attended college, then in Paris, where he met Ondine Green, the sister of a childhood friend from Cairo. They married in 1968.

Categories
Health

When a Surgeon Grew to become a Covid-19 Affected person: ‘I Had By no means Confronted the Actuality of Demise’

When a Surgeon Became a Covid-19 Patient: ‘I Had Never Faced the Reality of Death’

“He brought his culture of innovation,” Dr. Emond said. “And his personal capability, his ability to work for long hours, never quitting, never giving up, no matter how difficult the situation, carrying out operations that many would deem impossible.”

In his first year at Columbia, Dr. Kato and his team operated successfully on a 7-year-old girl, Heather McNamara, whose family had been told by several other hospitals that her abdominal cancer was inoperable. The surgery, which involved removing six organs and then putting them back in, took 23 hours.

More and more patients from around the country, and around the world, began seeking out Dr. Kato for operations that other hospitals could not or would not perform. He had also begun making trips to Venezuela to perform liver transplants for children and teach the procedure to local surgeons, and he created a foundation to help support the work there as well as in other Latin American countries.

As Dr. Kato’s colleagues struggled to save him, a waiting list of surgical patients clung to hopes that he would soon be able to save them.

Gradually, Dr. Pereira said, there were signs of recovery.

“You come in early in the morning to see him,” he said. “The hospital hallways are empty and everybody’s looking at each other, scared and anxious. You go into the intensive care unit dreading bad news, and the team is giving you a sort of hopeful thumbs-up that maybe he’s looking better.”

Dr. Kato spent about a month on a ventilator, and a week on ECMO. Like many people with severe Covid, he was tormented by frightening and vivid hallucinations and delusions. In one, he was arrested at the Battle of Waterloo. In another, he had been deliberately infected with anthrax; only a hospital in Antwerp could save him, but he could not get there. He saw the white light that some people describe after near-death experiences. “I felt like I died,” he said.

He had spent much of his adult life in hospitals, but never as a patient.

“I never got sick,” he said. “I had never faced the reality of death.”

Categories
Business

Snowflake CEO urges buyers to be affected person with inventory throughout cloud transition

Snowflake CEO urges investors to be patient with stock during cloud transition

Snowflake CEO Frank Slootman said Wednesday that shareholders need to be patient with the company’s stock because the cloud transition is not happening overnight.

“Our business is really going to conduct itself really over considerable, long periods of time,” Slootman said in an interview with CNBC’s Jim Cramer on “Mad Money.” “That’s sort of the message to investors to really understand we’re signing on here for a journey that’s five to 10 years.”

The comments came as shares of Snowflake tumbled as much as 8% in extended trading after the company reported fiscal first-quarter results.

While revenue grew 110% year over year to a better-than-expected $228.9 million, the data-analytics software firm also reported a net loss of $203.2 million. That’s up from $93.6 million in the same period a year earlier. At the same time, Snowflake also raised its full-year guidance for product revenue.

Snowflake went public in September in a record-breaking IPO, with shares closing that initial trading day at $253.93. However, the stock was below that level at Wednesday’s close. Snowflake shares are also down 16% year to date, as investors have rotated out of high-flying growth names into economically sensitive companies that stand to benefit from the Covid recovery.

Despite the recent moves on Wall Street, Slootman stressed that the company’s software is only becoming more important as enterprises shift away from databases tied to hardware.

“These are big, big changes that we are experiencing in the marketplace, and we’re just super happy to be in the middle of that and be an enabler of that,” he said, adding that Snowflake places its focus on growing at scale. “We’re not a growth-at-all-costs company.”

Categories
Business

The Fed’s affected person method could possibly be examined quickly.

The Fed’s patient approach could be tested soon.

The Federal Reserve is expected to keep its monetary policy in crisis mode when it concludes its final meeting on Wednesday, even if the economy improves.

The question now is how long it will be before the recovery is sufficiently advanced to stimulate the central bank to change course.

The Fed has kept rates near zero since March 2020 and is buying bonds at a pace of about $ 120 billion a month. These policies make many types of borrowing cheap and drive investors to riskier, more active investments – by allowing money to flow through the economic system and accelerating growth.

Fed officials are in no hurry to recall this support – even if coronavirus vaccines become widely available, the job market will heal and retail spending will rise, aided by government stimulus measures.

Instead, central bankers, including Fed Chairman Jerome H. Powell, have insisted that the economy is far from being completely healed. Millions are unemployed and the coronavirus is not entirely present in the US or worldwide. This threatens an uneven economic recovery and risks the spread of new variants

The federal Open Market Political Committee has announced that it will see “significant” progress towards its full employment and stable inflation goals before slowing monthly bond purchases. The hurdle for interest rate hikes is even higher: a return to maximum employment and inflation of more than 2 percent, which is expected to slightly exceed it for some time.

At their March meeting, central bank officials signaled that interest rates were likely to stay near zero through 2023 if the economy performed as expected. However, investors will be very focused on clues as to the way ahead when Mr. Powell holds a post-meeting press conference at 2:00 p.m. around 2:30 p.m. following the release of the committee’s statement.

“By the time of the June meeting, well over half of Americans should be partially vaccinated, and employment levels could be a few million higher than now, so the FOMC can discuss some noticeably improved results,” said Michael Feroli, chief executive of The US Economist at JP Morgan wrote in a research report. “For now, however, we think the committee’s message is unlikely to change from what it sent six weeks ago.”

However, the Fed’s commitment to patience – an approach that focuses on real, not just expected results – faces its first major challenge. With unemployment falling and inflation rising, two trends expected to emerge in the coming months, monetary policymakers are likely to be increasingly urged to recall their support to keep conditions from spiraling out of control.

But Mr Powell and colleagues have downplayed concerns about overheating and inflation warnings dating back to the 1970s and 1980s, arguing that the world has changed in recent decades.

“We had 3.5 percent unemployment in the last two years before the pandemic, which is a 50-year low,” Powell said in a recent 60-minute interview. “And inflation didn’t really react. This is not the economy we had 30 years ago. “

Categories
Health

How Pandemic Isolation Affected an Alzheimer’s Affected person in a Nursing Residence

How Pandemic Isolation Affected an Alzheimer's Patient in a Nursing Home

While the nurses came to change Peggy’s bedding, I spoke to her nurse in the hallway. When Peggy arrived at this facility about two weeks earlier, she had pressure ulcers on her heels and lower back. In Peggy’s room, her nurse changed her bandages and pointed out the wounds on her heels, which didn’t look bad, but on her back, just above her tailbone, a plate the size of a plate was sore, yellowish, and raw. “It’s gotten so much better,” said the nurse, running her finger over a circle about a third larger than the one I could see.

Both pressure ulcers and pulmonary embolisms can be caused by lying in the same position for too long. Nobody accused their previous nursing home of neglect, but they made it clear that the wounds were already there when they arrived. They had developed in the first four months of the Covid shutdown when my sister, her chief attorney, was not allowed to visit.

Her bandages changed and her sheets were fresh, Peggy turned on her side. Her eyes were calm and when she fell asleep I could see that she knew who I was.

While she slept, I explored her room to see what remnants of her curious and acquisitive life had been preserved in this institutional space. Her photo album was sticky and the pages crackled with age. I knew a lot of these photos. There she was like a bridesmaid, tall and deeply tanned, her blue eyes shining and holding the hand of our father, who lived not long after this picture was taken. There were photos of us as the five sisters we once were and one of Peggy, who was 10 years older than me and who acted as a surrogate mother when I graduated from high school. There was a photo of the friend who followed her to the end of the world, but to whom she could not commit. There are photos of our New Jersey home, nieces and nephews, green decks and swimming pools, and Peggy on her skis.

They came from a life none of us lived anymore, and they ended around 2005 when my mother sold her house and moved into assisted living, leaving Peggy without a landing for the first time in her life. Her bipolar illness, which she found difficult to manage, began to feed on the life she had built before Alzheimer’s quit the job.

Categories
Business

South Africa Covid variant detected in first New York affected person

NY Gov. Cuomo holds a press briefing as state prepares to distribute Covid vaccine

New York Governor Andrew Cuomo speaks out on Coronavirus Disease (COVID-19) on November 15, 2020 at Riverside Church in Manhattan, New York City, United States.

Andy Kelly | Reuters

Governor Andrew Cuomo said Sunday that a variant of Covid-19, first identified in South Africa, has reached New York.

The governor said at a news conference that the mutation, which experts fear may be resistant to some vaccines, was discovered in a resident of Nassau County. The announcement comes days after a Connecticut resident tested positive for the variant in a New York hospital.

“It is more important than ever for New Yorkers to stay vigilant, wear masks, wash hands, and stay socially aloof. We are currently in a race between our immunity and those variants that are actively trying to reproduce and we’ll just do it. ” You can win this race if we stay smart and disciplined, “said Cuomo.

The South African variant, known as B.1.351, was first discovered in the US in late January and has been found in at least 10 states, according to the Centers for Disease Control and Prevention. 21 infections have been reported in the country.

The mutation is one of three strains of very high concern monitored by the agency, along with variants that were first identified in the UK and Japan.

The CDC has said preliminary evidence from untested publications suggests the Moderna vaccine may be “less effective” against the South African variant. It was indicated that further studies are needed.

The Moderna vaccine is one of two federally approved vaccines in the United States. Three other vaccines are currently in clinical trials.

Cuomo’s announcement came as the number of new cases and hospitalizations continued to decline in New York and across the country. Some public health experts have warned that the new mutations that are believed to be more transmissible could reverse these trends.

Subscribe to CNBC Pro for the live TV stream, deep insights and analysis of how to invest during the next president’s term.

Categories
Health

Covid Affected person Examine Reveals Some Profit From an Arthritis Drug

Covid Patient Study Shows Some Benefit From an Arthritis Drug

Adding an arthritis drug called baricitinib to Covid treatment regimens that contains the antiviral drug remdesivir can cut recovery times by a day or more, especially for those who are seriously ill, according to a study published Friday.

The results of a government-sponsored clinical trial were released more than three weeks after the Food and Drug Administration received an emergency approval for double treatment. Earlier this month, some experts said they were uncomfortable using medication without a chance to review the underlying data backing their performance. Last month, the World Health Organization also recommended rejecting remdesivir for treating Covid patients as there was no evidence of its use.

In previous press releases, limited results were disclosed showing that hospitalized Covid patients treated with baricitinib and remdesivir recovered one day faster than those who received remdesivir alone.

Some questioned the adoption of the combination treatment because baricitinib came at a high price – which could be around $ 1,500 per patient – and also cited side effects like blood clots. Several doctors also wondered if adding baricitinib would be worth it, since steroids like dexamethasone were cheap and widely available. Both baricitinib and dexamethasone are believed to suppress the excessive inflammation that causes many severe cases of Covid.

The new paper, published in the New England Journal of Medicine, adds some granularity to the results and shows that certain subsets of patients benefited far more from the addition of baricitinib than others. The study included more than 1,000 hospital patients with Covid, all of whom received remdesivir. People who were sick enough to need high doses of supplemental oxygen or non-invasive ventilation recovered eight days faster when baricitinib was included in their medication.

In these groups, “I think the data clearly support a role for baricitinib,” said Dr. Boghuma Kabisen Titanji, an infectious disease doctor at Emory University who pioneered early studies of baricitinib against the coronavirus.

Dr. Titanji also noted that the data suggested that certain patients may be less likely to die or need a ventilator when taking baricitinib in addition to remdesivir. However, like those showing faster recovery times, these results were inconsistent among study participants.

Dr. Lauren Henderson, a pediatric rheumatologist at Boston Children’s Hospital, said she was encouraged by the results and the prospect of another option in the coronavirus treatment arsenal.

She and several other experts added that they may still have a tendency to use dexamethasone as a treatment for seriously ill Covid-19 patients who needed respiratory support.

In contrast to baricitinib, studies have shown that dexamethasone inhibits mortality in seriously ill Covid patients. It’s also inexpensive and easy to get hold of, while baricitinib is more of a specialty drug and may pose barriers to the supply chain, said Dr. Erin McCreary, Infectious Disease Pharmacist at the University of Pittsburgh.

New treatments for Covid-19

Things to know about Covid-19 treatment

Confused By The Terms To Treat Covid-19? Let us help:

    • ACE-2: A protein that sits on the surface of certain types of human cells. The coronavirus has to bind to ACE-2 in order to enter cells.
    • Adverse event: A health problem that occurs in volunteers in a clinical trial with a vaccine or drug. An adverse event is not always caused by the treatment tested in the study.
    • Antibody: A protein produced by the immune system that can attach to a pathogen such as the coronavirus and prevent it from infecting cells.
    • Antiviral drug: A drug that affects the ability of a virus to replicate in cells. The first drug approved in the United States for Covid-19, Remdesivir, is antiviral.
    • Approval, Licensing, and Approval for Emergency Use: Medicines, vaccines and medical devices cannot be sold in the US for no profit approval by the Food and Drug Administration, also known as Licensing. After a company submits the results of clinical studies to the FDA for review, the agency decides whether the product is safe and effective. This process usually takes many months. If the country faces an emergency – like a pandemic – a company can file an application instead Emergency approvalthat can be granted much faster.
    • Compassionate Use: A term used to describe treatments given to seriously ill people even though they have not yet been approved for that use by the Food and Drug Administration.
    • Cytokine storm: An overactive immune system reaction that can lead to massive inflammation and tissue damage. Cytokine storms can be responsible for many of the severe cases of Covid-19, and a number of researchers are testing drugs that may calm them down.
    • Interferon: A molecule of the immune system. Certain types of interferons can cause inflammation in the body while others can contain it. Still other types can stimulate cells to strengthen their defenses against viruses. Researchers are investigating whether treating synthetic interferons can help people fight off the coronavirus.
    • Monoclonal Antibodies: Monoclonal antibodies made in a laboratory mimic the natural antibodies made by the immune system. A number of companies have developed these treatments for Covid-19. President Trump received Regeneron’s antibody treatment soon after the disease was diagnosed.
    • Phases 1, 2 and 3 studies: Clinical trials typically take place in three phases. Phase 1 studies typically involve a few dozen people to determine whether a vaccine or drug is safe. In Phase 2 trials that involve hundreds of people, researchers can try different doses and take more measurements of the vaccine’s effects on the immune system. Phase 3 trials, involving thousands or tens of thousands of volunteers, determine the safety and effectiveness of the vaccine or medicine by waiting to see how many people are protected from the disease it is intended to be used against.
    • Placebo: A substance with no therapeutic effect that is widely used in clinical trials. For example, to see if a vaccine can prevent Covid-19, researchers can inject the vaccine into half of their volunteers while the other half are given a placebo with salt water. You can then compare how many people are infected in each group.
    • Post-market surveillance: The surveillance that occurs after a vaccine or drug has been approved and regularly prescribed by doctors. This typically confirms that the treatment is safe. Rarely, side effects are noted in certain groups of people that were overlooked during clinical trials.
    • Preclinical Research: Studies that take place prior to the start of a clinical trial typically include experiments that test a treatment on cells or animals.
    • Test protocol: A series of procedures that must be performed during a clinical trial.
    • Retrospective study: A study that analyzes data collected in the past to determine how effective a treatment is. Retrospective studies can provide useful information, but they are not as definitive as randomized clinical studies.
    • Spike protein: A protein that sits on the surface of coronaviruses. The spike protein binds to the ACE-2 receptor on human cells using a region called the receptor binding domain (RBD). As soon as the protein accumulates, the virus can enter the cell. Many vaccines and monoclonal antibody treatments are designed to stick to the tip.
    • Standard of care: A treatment that is accepted by medical experts as an appropriate method to treat a specific type of disease. Once a standard for treating a disease is established, new experimental treatments are usually tested against it rather than a placebo.

Several experts pointed to another study by the National Institutes of Health that seeks to directly compare two combination treatment regimens: one in which hospital patients receive remdesivir and baricitinib, and one in which remdesivir is paired with dexamethasone. Dr. McCreary also noted the importance of studying patients receiving both baricitinib and dexamethasone “to see if there is any incremental benefit.”

Dr. Andre Kalil, an infectious disease doctor at the University of Nebraska Medical Center and lead researcher on the new paper, noted that while dexamethasone had already become a widely accepted treatment for Covid-19, the steroid still needed further study. He cited “a variety of serious safety issues” with the drug that warranted thorough investigation.

Like other steroids, dexamethasone, which largely reduces inflammation, can be associated with a variety of undesirable side effects, including worsening conditions like diabetes or osteoporosis.